Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
Adiutrix Therapeutics has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $1,377,583 between 2024 and 2025. These are non-dilutive federal research grants, not equity financing. The company is based in New York, New York.
No investors recorded yet for Adiutrix Therapeutics.
Add an investorAdiutrix Therapeutics has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Adiutrix Therapeutics.
Add diversity data